Dirk G. Brockstedt - 13 Nov 2024 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Signature
/s/ Rodney Young, Attorney-in-Fact
Issuer symbol
RAPT
Transactions as of
13 Nov 2024
Net transactions value
$0
Form type
4
Filing time
15 Nov 2024, 20:00:13 UTC
Previous filing
01 Feb 2024
Next filing
03 Feb 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -20,000 -100% $0.000000 0 13 Nov 2024 Common Stock 20,000 $44.66 Direct F1
transaction RAPT Employee Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 13 Nov 2024 Common Stock 20,000 $1.57 Direct F1
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -50,000 -100% $0.000000 0 13 Nov 2024 Common Stock 50,000 $19.53 Direct F2, F3
transaction RAPT Employee Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 13 Nov 2024 Common Stock 50,000 $1.57 Direct F2, F3
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -55,000 -100% $0.000000 0 13 Nov 2024 Common Stock 55,000 $19.86 Direct F4, F5
transaction RAPT Employee Stock Option (right to buy) Award $0 +55,000 $0.000000 55,000 13 Nov 2024 Common Stock 55,000 $1.57 Direct F4, F5
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -56,000 -100% $0.000000 0 13 Nov 2024 Common Stock 56,000 $29.05 Direct F6, F7
transaction RAPT Employee Stock Option (right to buy) Award $0 +56,000 $0.000000 56,000 13 Nov 2024 Common Stock 56,000 $1.57 Direct F6, F7
transaction RAPT Employee Stock Option (right to buy) Disposed to Issuer $0 -75,000 -100% $0.000000 0 13 Nov 2024 Common Stock 75,000 $24.75 Direct F8, F9
transaction RAPT Employee Stock Option (right to buy) Award $0 +75,000 $0.000000 75,000 13 Nov 2024 Common Stock 75,000 $1.57 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 30, 2020 and is fully vested.
F2 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2021.
F3 1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting start date of January 1, 2021.
F4 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2022.
F5 1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2022.
F6 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2023.
F7 1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2023.
F8 The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 1, 2024.
F9 1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2024.